The Cancer Letter

Inside information on cancer research and drug development

40-10 Twenty Years Later

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE

NIH to Review Intramural Program NCI’s Intramural Spending is 17 Percent, Higher than 11.1 Percent NIH-Wide LevelBy Paul Goldberg

To access this subscriber-only content please log in or renew you subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Byline
Editor & Publisher

YOU MAY BE INTERESTED IN

News Analysis

Biden requests $6.5B to fund cancer-focused ARPA-H, an advanced research agency to be housed within NIH

President Joe Biden April 9 announced his FY2022 budgetary plans for ARPA-H—Advanced Research Projects Agency-Health—a federal entity designed to “deliver breakthroughs to find cures for cancer and other diseases.” In his initial White House budget proposal—dubbed skinny budget, or budget-lite—Biden is requesting $6.5 billion to fund ARPA-H.  “The discretionary request calls for $6.5 billion to...

By Matthew Bin Han Ong
Byline
Editor & Publisher